?

Brown Michael S

Director
Regeneron Pharmaceuticals, Inc.
US, Tarrytown [HQ]
CIK 1174475

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
1,548
Price per Share :
$703.43
Equivalence :
$1,088,909.64

Transaction History

  • A
    Form 4
    1,548 Shares After Transaction
    Value : $n/a
    $0.0
    01/02/25
  • Footnotes:
    #1 Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.
  • M
    Form 4
    2,554 Shares After Transaction
    Value : $1,597,782.40
    $733,203.20
    05/28/24
  • S
    Form 4
    1,382 Shares After Transaction
    Value : $1,347,256.52
    Sold $1,142,535.92
    05/28/24
  • M
    Form 4
    2,917 Shares After Transaction
    Value : $1,824,875.20
    $960,296.00
    06/14/24
  • S
    Form 4
    1,382 Shares After Transaction
    Value : $1,437,280.00
    Sold $1,596,400.00
    06/14/24